glaucoma tozammal

Upload: tozammal

Post on 30-May-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/14/2019 Glaucoma Tozammal

    1/31

    Skeletal muscle relxants

    Nicotinic (Muscle) receptor blockers Skeletal muscle relaxants.

    Nicotinic (Nerve) receptor blockers Ganglion blockers

  • 8/14/2019 Glaucoma Tozammal

    2/31

    Skeletal muscle relaxants

    Skeletal muscle relaxants blockperipherally at the

    neuromuscular junction (Nicotinic

    receptor of Ach Muscle). Types of Skeletal muscle relaxants:

    Competitive (Non-depolarizing)

    Non-competitive (Depolarizing)Directly acting Muscle relaxants

    Miscellaneous : Aminoglycosides

  • 8/14/2019 Glaucoma Tozammal

    3/31

    Skeletal muscle relaxantsPharmacokinetics :

    Most peripheral NM blockers are quaternarycompounds not absorbed orally.

    Administered intravenously.

    Do not cross blood brain barrier or placenta SCh is metabolized by Pseudocholinesterase.

    Atracurium is inactivated in plasma by spontaneousnon-enzymatic degradation (Hoffman

    elimination).

  • 8/14/2019 Glaucoma Tozammal

    4/31

    Skeletal muscle relaxants

    Neuromuscular blockers

    Non - depolarizing ( competitive )Long acting : Pancuronium,

    Pipecuronium,Intermediate : Vecuronium, Rocuronium,Atracurium

    Short acting : Mivacurium

    Depolarizing blockers : (Non-competitive)Succinylcholine (Suxamethonium)

  • 8/14/2019 Glaucoma Tozammal

    5/31

    Skeletal muscle relaxants

    Neuromuscular blocking agents :

    Non-depolarizing agents (Competitiveblockers).

    Mechanism of action :These have anaffinity for the Nicotinic (NM) receptorsat the muscle end plates but have no

    intrinsic activity. The antagonism is surmountable by

    increasing the conc. of Ach.

  • 8/14/2019 Glaucoma Tozammal

    6/31

    Skeletalmusclerelaxants

    Duration mins

    Pancuronium 40-80

    Pipecuronium 50-100

    Vecuronium 20-40

    Atracurium 20-40

    Rocuronium 20-40

    Succinylcholine

    3-6

  • 8/14/2019 Glaucoma Tozammal

    7/31

    Skeletal muscle relaxants

    Depolarizing block ( Non-competitive ) :

    Succinylcholine have affinity and submaximal intrinsic activity at NM receptors.

    They open Na channels whichcause initial twitching and fasciculations.

    It do not dissociate rapidly from thereceptors resulting in prolonged

    depolarization and inactivation of the Na +channels

  • 8/14/2019 Glaucoma Tozammal

    8/31

    Skeletal muscle relaxants

    Depolarizing block (Non-competitive) :Succinylcholine

    It causes muscle pain.

    It causes hyperkalemia.

    Malignant Hyperthermia.

  • 8/14/2019 Glaucoma Tozammal

    9/31

    CompetitiveNon-depolarizing

    Non-CompetitiveDepolarizing

    Paralysis Flaccid Fasciculations--- Flaccid

    Neostigmine Antagonizes Exaggerate /no effect.

    Examples Pancuronium Succinylcholine

  • 8/14/2019 Glaucoma Tozammal

    10/31

    Skeletal muscle relaxants

    USES OF NEUROMUSCULAARBLOCKERS :

    Adjuvant in general anesthesia

    Intubation and endoscopies

    Brief procedure reduction of #.

  • 8/14/2019 Glaucoma Tozammal

    11/31

    Skeletal muscle relaxants

    Directly acting muscle relaxants :

    Dantrolene :Depolarization triggered release of

    calcium from the sarcoplasmiccontraction is blocked / reduced.

    Dantrolene is used orally/ i.v to reducesspasticity in hemiplegia and cerebral

    palsy. It is the drug of choice malignant

    hyperthermia

  • 8/14/2019 Glaucoma Tozammal

    12/31

    Central skeletal musclerelaxants

    These produce selective action in thecerebrospinal axis acts as skeletal musclerelaxants

    Theses depress the spinal and supraspinalpolysynaptic reflexes involved in theregulation of muscle tone.

    Polysynaptic reflex in the RAS involved inthe wakefulness also depressed sedativeaction.

  • 8/14/2019 Glaucoma Tozammal

    13/31

    Central skeletal musclerelaxants

    Examples of centrally acting skeletalmuscle relaxants :

    Chlorzoxazone, Methocarbamol

    Diazepam

    Baclofen

  • 8/14/2019 Glaucoma Tozammal

    14/31

  • 8/14/2019 Glaucoma Tozammal

    15/31

    Ganglion blockers

    Ganglion blockersare competitiveantagonist at NN receptors inautonomic ganglia.

    Net effect of the blocker is to reducethe predominant tone.

    Effects are predictable and depend

    on the relative dominance in terms ofPANS and SANS.

  • 8/14/2019 Glaucoma Tozammal

    16/31

  • 8/14/2019 Glaucoma Tozammal

    17/31

    Ganglion blockers

    Effectororgans

    Dominantsystem

    Effects of ganglionicblockade

    Arterioles/veins

    SANS Vasodilatation, hypotension

    Sweat glands SANS Anhydrosis

    Genitals PANS/SANS Impotence

    Heart PANS TachycardiaIris PANS Mydriasis

    Ciliary PANS Cycloplegia

    Bladder PANS Urinary retention

    Salivary PANS Xerostomia

  • 8/14/2019 Glaucoma Tozammal

    18/31

    Ganglion blockers

    Ganglionic blocking agents :

    Mecamylamine, Trimethaphan.

    It is used in severe hypertension.

  • 8/14/2019 Glaucoma Tozammal

    19/31

    Ganglion blocking agents

    Ganglion blocking agents block theautonomic reflexes, including changes inheart rate elicited by increase / decrease

    in blood pressure. Hexamethonium will block the reflex

    bradycardia that occurs whenphenylephrine causes vasoconstriction, it

    will not block a bradycardia that resultsfrom direct activation of muscarinicreceptors in heart.

  • 8/14/2019 Glaucoma Tozammal

    20/31

  • 8/14/2019 Glaucoma Tozammal

    21/31

    Glaucoma

  • 8/14/2019 Glaucoma Tozammal

    22/31

  • 8/14/2019 Glaucoma Tozammal

    23/31

    Glaucoma

    Glaucoma is increased intraocular pressure.

    Intraocular pressure is determined by thebalance between fluid input & drainage out of

    the globe----- aqueous humor produced by ciliaryepitheliumand drained at the filtrationangleof the anterior chamber.

    Objective of glaucoma therapy: ---increase outflow& ordecreaseproduction of aqueous humor.

  • 8/14/2019 Glaucoma Tozammal

    24/31

    Glaucoma

    Major route of aqueous humordrainage is ~ 90% throughtrabecular route ~

    10% passes through within the ciliarymuscle into episceral vessels(uveosceral flow)

  • 8/14/2019 Glaucoma Tozammal

    25/31

    D f l

  • 8/14/2019 Glaucoma Tozammal

    26/31

    Drugs for glaucoma

    Beta blockers

    Alpha agonist

    CA inhibitor

    Pilocarpine PG analog

  • 8/14/2019 Glaucoma Tozammal

    27/31

  • 8/14/2019 Glaucoma Tozammal

    28/31

    Glaucoma

    Muscarinic cholinomimetics : Direct-acting : Pilocarpine, Carbachol

    Indirect-acting : Physostigmine

    ----> contraction of ciliary muscle open

    the trabecular spaces so that aqueoushumor drains more easily.----> iris pulled from angle of anteriorchamber widening the filtration angle and

    opening the trabecular network----> increased outflow of aqueous humor----> decreased intraocular pressure.

  • 8/14/2019 Glaucoma Tozammal

    29/31

    Glaucoma

    Beta adrenoceptor blockers :Timolol, Betaxolol

    ----> decreased production ofaqueous humor by ciliary epithelium.

    No change in pupil size, Noheadache, No fluctuations in IOT arethe advantages of the beta blockers.

  • 8/14/2019 Glaucoma Tozammal

    30/31

    Glaucoma

    Carbonic anhydrase inhibitors : Dorzolamide

    It blocks the formation of aqueous humor byblocking the carbonic anhydrase enzyme

    required for the synthesis of it.Alpha Adrenoceptor agonists :

    Apraclonidine----> alpha 2 agonist acts by reducing the

    formation of aqueous humor.

  • 8/14/2019 Glaucoma Tozammal

    31/31

    Glaucoma

    Prostaglandins :

    Latanaprost

    It increases the aqueous drainage through

    the alternate pathways uveoscleral route. May eventually cause permanent darkening

    of the iris to brown (heterochromia),eyelashesreddening of the eyes.